Cyto Magnesium Bisglycinate 400
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Bisglycinate de magnésium | 200 milligramme | Not calculated |
Non-medicinal ingredients
Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Mesures ; maximum: 2 Mesures | 1 Tous les jours |
Uses authorised in Canada
Helps to maintain the body's ability to metabolize nutrients. Helps in the development and maintenance of bones and teeth. Helps in tissue formation. Helps to maintain proper muscle function. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
At 2 scoops, some people may experience diarrhoea.
Product record
- Other names
- Cyto Magnesium Bisglycinate Powder 400
- Licence holder
- Cyto-Matrix Inc.
- NPN or DIN-HM
- 80088773
- Status
- Inactive licence
- Licence date
- 17 October 2018
- Revision date
- 4 January 2021
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80088773
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Cyto Magnesium Bisglycinate 400 (Cyto-Matrix Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80088773-cyto-magnesium-bisglycinate-400, updated 4 January 2021.